DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

company name or ticker
Company Photos
(Click to zoom)

Why ETFs That Give Every Stock Equal Weight Can Be Worth a Look

This Terrifying Cancer May Finally Be Treatable

Celldex Therapeutics reported some highly encouraging data for its experimental brain cancer vaccine Rintega at the recent ASCO meeting. Could this vaccine prove to be a game-changer in the fight against this deadly disease?

5 Stocks to Buy for June

Big Downgrades Outweigh Upgrades For Pharma's Biggest Products

Agenus Gains after Merck Extends Immuno-Oncology Ties - Analyst Blog

3 Dividend Leaders That Just Broke Out Of Bases

Merck Announces Results from Investigational IMPROVE-IT Study of VYTORIN Published in NEJoM

Will GlaxoSmithKline Cut Its 6% Dividend?

Bristol-Myers Rides The Immunotherapy Hype Cycle

The 4 Stocks That Weighed on the Dow Tuesday